Mirum Pharmaceuticals, Inc. (MIRM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Mirum is a rare disease company focused on delivering life-changing medicines to patients with rare diseases [2] - The company is entering a pivotal year with strong commercial performance anticipated [2] Financial Performance - For the year, Mirum announced an estimated total product revenue of $520 million [2] - Guidance for 2026 is projected to be between $630 million and $650 million [2]